Search

everythinglearnresearchcommunity

for

Search:↓

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Older adults use lifestyle drugs to improve life quality and appearance, but caution is needed due to side effects and potential abuse.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Children's hair diseases include compulsive hair-pulling, easily plucked hair, scalp fungal infections, and head lice, each requiring specific diagnosis and treatment.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

The robotic system for hair restoration surgery works well, giving similar results to manual techniques after 9 months.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Optical Coherence Tomography has potential in diagnosing hair loss and monitoring blood clotting, and could be improved for deeper tissue observation and better hair loss understanding.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

New hair loss treatments show promise, but more research is needed to confirm their effectiveness.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

Cosmetics can help with mild skin problems and daily care but must be used carefully to avoid skin irritation.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Hair microscopy is a useful and affordable way to diagnose hair disorders.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.